The American Society of Clinical Oncology recently published an oncology drug rating scale, in the Journal of Clinical Oncology. The scorecard was designed to simplify decision making by listing benefits, side effects and costs. Read more here. (Source: Tracy Staton, FiercePharma, 6/23/15)
You are here: / / What will Big Pharma Think of the New ASCO Scorecard?